Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aequus PharmaceuticalsAQSZF Days Inventory is 39.33 as of Sep. 2025, which is 90% below its 10-year median of 384.53. The stock has 6 warning signs investors should review. Among 923 Drug Manufacturers companies, Aequus Pharmaceuticals ranks better than 88.84% on this metric.
The historical rank and industry rank for Aequus Pharmaceuticals's Days Inventory or its related term are showing as below:
AQSZF'
s Days Inventory Range Over the Past 10 Years
Min: 72.82 Med: 384.53 Max: 1116.22
Current: 72.82
During the past 12 years, Aequus Pharmaceuticals's highest Days Inventory was 1116.22. The lowest was 72.82. And the median was 384.53.
AQSZF's Days Inventory is ranked better than 88.84% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs AQSZF: 72.82
Aequus Pharmaceuticals's Days Inventory
declined
from Sep. 2024 (161.38) to Sep. 2025 (39.33).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aequus Pharmaceuticals's Inventory Turnover for the
three
months ended in Sep. 2025 was 2.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aequus Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Sep. 2025 was 0.21.
Aequus Pharmaceuticals (OTCPK:AQSZF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aequus Pharmaceuticals's Inventory Turnover for the
three
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aequus Pharmaceuticals's Inventory to Revenue for the
three
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aequus Pharmaceuticals Days Inventory Related Terms
Aequus Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Aequus Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSZF vs GCAN, STEK, CBSTQ: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aequus Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aequus Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aequus Pharmaceuticals (AQSZF) has a Days Inventory of 39.33 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aequus Pharmaceuticals and its competitors. This is 90% below median its historical median of 384.53. Over the past decade, Aequus Pharmaceuticals' Days Inventory has ranged from 72.82 to 1,116.22. According to the industry distribution chart, Aequus Pharmaceuticals ranks #103 out of 923 companies in the Drug Manufacturers industry, placing it in the top 11.2%.
Is Aequus Pharmaceuticals' Days Inventory too high?
Aequus Pharmaceuticals' current Days Inventory of 39.33 is 90% below median its 10-year median of 384.53. Over the past 10 years, this metric has ranged from a low of 72.82 to a high of 1,116.22. The Drug Manufacturers industry median Days Inventory is 164.38. Aequus Pharmaceuticals' value of 39.33 is 76.1% below this industry median. Based on the distribution chart, Aequus Pharmaceuticals ranks #103 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Aequus Pharmaceuticals' Days Inventory compare to GCAN and STEK?
According to the Drug Manufacturers industry distribution chart, Aequus Pharmaceuticals ranks #103 out of 923 companies for Days Inventory. This places Aequus Pharmaceuticals in the top 11% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.38. Aequus Pharmaceuticals' value of 39.33 is 76.1% below this benchmark. Historically, Aequus Pharmaceuticals' own Days Inventory has ranged from 72.82 to 1,116.22 over the past decade. While the company's 10-year median is 384.53 vs. the industry median of 164.38, Aequus Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aequus Pharmaceuticals's current Days Inventory of 39.33 is 76.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aequus Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aequus Pharmaceuticals's current Days Inventory is 39.33, which is 90% below median its own 10-year median of 384.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aequus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Aequus Pharmaceuticals (AQSZF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 74% below its estimated fair value. The current Days Inventory is 39.33, which is 90% below median its 10-year median of 384.53 and 76.1% below the Drug Manufacturers industry median of 164.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aequus Pharmaceuticals (AQSZF), the current Days Inventory is 39.33 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products namely Tacrolimus IR and Vistitan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSZF has been successfully added to your 
